Iron Triangle Partners LP's Q2 2023 13F: 7 new positions, 12 exits
Form 13F-HR for the quarter ended Jun 30, 2023 · filed Aug 14, 2023 · 22 reported positions · accession 0001172661-23-003009
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| New | UNIVERSAL HLTH SVCS INC (UHS) | — | 10.2% | +10.2 pts | +470K sh | new |
| Exited | SANOFI (SNY) | 9.3% | — | −9.3 pts | −1.18M sh | −100% |
| New | EXACT SCIENCES CORP (EXAS) | — | 6.4% | +6.4 pts | +500K sh | new |
| New | BOSTON SCIENTIFIC CORP (BSX) | — | 6.3% | +6.3 pts | +850K sh | new |
| New | UNITED THERAPEUTICS CORP DEL (UTHR) | — | 6.1% | +6.1 pts | +200K sh | new |
| Increased | ICON PLC (ICLR) | 5.9% | 12.0% | +6.1 pts | +160K sh | +84% |
| Exited | UNITEDHEALTH GROUP INC (UNH) | 5.5% | — | −5.5 pts | −80,000 sh | −100% |
| Exited | GILEAD SCIENCES INC (GILD) | 5.0% | — | −5.0 pts | −420K sh | −100% |
| Exited | EVOLENT HEALTH INC (EVH) | 4.7% | — | −4.7 pts | −1M sh | −100% |
| Exited | CHARLES RIV LABS INTL INC (CRL) | 3.8% | — | −3.8 pts | −130K sh | −100% |
| Exited | IDEXX LABS INC (IDXX) | 3.6% | — | −3.6 pts | −50,000 sh | −100% |
| Exited | LEGEND BIOTECH CORP (LEGN) | 3.5% | — | −3.5 pts | −500K sh | −100% |
| Reduced | DEXCOM INC (DXCM) | 5.7% | 2.6% | −3.1 pts | −190K sh | −56% |
| Exited | SAREPTA THERAPEUTICS INC (SRPT) | 3.2% | — | −3.2 pts | −160K sh | −100% |
| New | ALIGN TECHNOLOGY INC (ALGN) | — | 3.2% | +3.2 pts | +65,000 sh | new |
| New | GLAUKOS CORP (GKOS) | — | 3.0% | +3.0 pts | +310K sh | new |
| Increased | ABBVIE INC (ABBV) | 7.4% | 8.3% | +1.0 pts | +130K sh | +41% |
| Exited | SCHRODINGER INC (SDGR) | 2.3% | — | −2.3 pts | −596K sh | −100% |
| New | TRANSMEDICS GROUP INC (TMDX) | — | 2.1% | +2.1 pts | +180K sh | new |
| Exited | CUTERA INC (CUTRQ) | 2.0% | — | −2.0 pts | −600K sh | −100% |
| Reduced | SURGERY PARTNERS INC (SGRY) | 4.1% | 3.6% | −0.5 pts | −235K sh | −29% |
| Exited | 2SEVENTY BIO INC (TSVT) | 1.3% | — | −1.3 pts | −869K sh | −100% |
| Increased | ESTABLISHMENT LABS HLDGS INC (ESTA) | 4.2% | 5.1% | +0.9 pts | +113K sh | +27% |
| Increased | BROOKDALE SR LIVING INC (BKD) | 1.1% | 2.4% | +1.3 pts | +1.48M sh | +55% |
| Increased | SPRINGWORKS THERAPEUTICS INC (SWTX) | 1.2% | 1.7% | +0.5 pts | +152K sh | +49% |
| Exited | STEREOTAXIS INC (STXS) | 0.5% | — | −0.5 pts | −1.83M sh | −100% |
| Reduced | COOPER COS INC (COO) | 4.6% | 3.9% | −0.6 pts | −10,000 sh | −12% |
| Increased | 10X GENOMICS INC (TXG) | 2.8% | 2.9% | +0.1 pts | +30,000 sh | +9% |
| Reduced | OLINK HLDG AB (OLK) | 1.3% | 0.8% | −0.5 pts | −85,205 sh | −21% |
| Increased | PACIFIC BIOSCIENCES CALIF IN (PACB) | 3.8% | 4.4% | +0.5 pts | +100K sh | +4% |
| Reduced | 908 DEVICES INC (MASS) | 1.3% | 0.8% | −0.5 pts | −150K sh | −14% |
| Reduced | ACADIA HEALTHCARE COMPANY IN (ACHC) | 5.3% | 5.5% | +0.2 pts | −9,259 sh | −2% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 69.8% of the equity book
Changes in the top 10 this quarter: UHS entered · EXAS entered · BSX entered · UTHR entered · ESTA entered · PACB entered · SNY left · DXCM left · UNH left · GILD left · EVH left · COO left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | ICON PLC (ICLR) | 5.9% | 12.0% | |
| 2 | UNIVERSAL HLTH SVCS INC (UHS) | 0.0% | 10.2% | Entered the top 10 |
| 3 | ABBVIE INC (ABBV) | 7.4% | 8.3% | |
| 4 | EXACT SCIENCES CORP (EXAS) | 0.0% | 6.4% | Entered the top 10 |
| 5 | BOSTON SCIENTIFIC CORP (BSX) | 0.0% | 6.3% | Entered the top 10 |
| 6 | UNITED THERAPEUTICS CORP DEL (UTHR) | 0.0% | 6.1% | Entered the top 10 |
| 7 | INTUITIVE SURGICAL INC (ISRG) | 4.4% | 5.6% | |
| 8 | ACADIA HEALTHCARE COMPANY IN (ACHC) | 5.3% | 5.5% | |
| 9 | ESTABLISHMENT LABS HLDGS INC (ESTA) | 4.2% | 5.1% | Entered the top 10 |
| 10 | PACIFIC BIOSCIENCES CALIF IN (PACB) | 3.8% | 4.4% | Entered the top 10 |
| — | SANOFI (SNY) | 9.3% | 0.0% | Left the top 10 |
| — | DEXCOM INC (DXCM) | 5.7% | 2.6% | Left the top 10 |
| — | UNITEDHEALTH GROUP INC (UNH) | 5.5% | 0.0% | Left the top 10 |
| — | GILEAD SCIENCES INC (GILD) | 5.0% | 0.0% | Left the top 10 |
| — | EVOLENT HEALTH INC (EVH) | 4.7% | 0.0% | Left the top 10 |
| — | COOPER COS INC (COO) | 4.6% | 3.9% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| New | NEUROCRINE BIOSCIENCES INC (NBIX) | Put | 0 | 196K | $18.5M |